Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN SUN PHARMA LUPIN/
SUN PHARMA
 
P/E (TTM) x 40.7 43.5 93.6% View Chart
P/BV x 6.0 7.0 85.6% View Chart
Dividend Yield % 0.2 0.7 35.1%  

Financials

 LUPIN   SUN PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
SUN PHARMA
Mar-23
LUPIN/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs7991,072 74.5%   
Low Rs583790 73.8%   
Sales per share (Unadj.) Rs365.8182.9 200.0%  
Earnings per share (Unadj.) Rs9.835.7 27.6%  
Cash flow per share (Unadj.) Rs29.246.2 63.2%  
Dividends per share (Unadj.) Rs4.0011.50 34.8%  
Avg Dividend yield %0.61.2 46.9%  
Book value per share (Unadj.) Rs270.7233.4 116.0%  
Shares outstanding (eoy) m454.982,399.34 19.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.95.1 37.1%   
Avg P/E ratio x70.226.1 269.2%  
P/CF ratio (eoy) x23.720.1 117.5%  
Price / Book Value ratio x2.64.0 64.0%  
Dividend payout %40.732.2 126.1%   
Avg Mkt Cap Rs m314,3812,233,361 14.1%   
No. of employees `000NANA-   
Total wages/salary Rs m30,87282,960 37.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,417438,857 37.9%  
Other income Rs m1,5098,199 18.4%   
Total revenues Rs m167,926447,055 37.6%   
Gross profit Rs m17,206112,900 15.2%  
Depreciation Rs m8,80725,294 34.8%   
Interest Rs m2,7431,720 159.5%   
Profit before tax Rs m7,16594,084 7.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,6888,476 31.7%   
Profit after tax Rs m4,47785,608 5.2%  
Gross profit margin %10.325.7 40.2%  
Effective tax rate %37.59.0 416.4%   
Net profit margin %2.719.5 13.8%  
BALANCE SHEET DATA
Current assets Rs m124,513398,619 31.2%   
Current liabilities Rs m92,654199,064 46.5%   
Net working cap to sales %19.145.5 42.1%  
Current ratio x1.32.0 67.1%  
Inventory Days Days26147 17.8%  
Debtors Days Days9895 103.3%  
Net fixed assets Rs m103,490376,960 27.5%   
Share capital Rs m9102,399 37.9%   
"Free" reserves Rs m122,246557,555 21.9%   
Net worth Rs m123,156559,954 22.0%   
Long term debt Rs m2750-   
Total assets Rs m228,003775,794 29.4%  
Interest coverage x3.655.7 6.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 129.0%   
Return on assets %3.211.3 28.1%  
Return on equity %3.615.3 23.8%  
Return on capital %8.017.1 46.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,057154,053 31.2%   
Fx outflow Rs m21,75271,511 30.4%   
Net fx Rs m26,30682,541 31.9%   
CASH FLOW
From Operations Rs m18,97249,593 38.3%  
From Investments Rs m-12,868-79,437 16.2%  
From Financial Activity Rs m-3,37323,761 -14.2%  
Net Cashflow Rs m2,7321,155 236.6%  

Share Holding

Indian Promoters % 46.8 54.5 85.8%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 36.6 125.3%  
FIIs % 16.1 17.1 94.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 45.5 116.3%  
Shareholders   281,542 612,626 46.0%  
Pledged promoter(s) holding % 0.0 2.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Lupin vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs Sun Pharma Share Price Performance

Period Lupin Sun Pharma S&P BSE HEALTHCARE
1-Day 1.23% 1.45% 1.18%
1-Month 0.15% 3.70% -0.75%
1-Year 151.13% 65.76% 61.82%
3-Year CAGR 17.13% 39.76% 18.16%
5-Year CAGR 17.42% 27.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.

You may visit here to review the dividend history of Lupin, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.